NCT05023018 2026-03-02NEO100 and High-Grade MeningiomaNeonc Technologies, Inc.Phase 2 Recruiting30 enrolled
NCT06357377 2026-01-14A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain TumorsNeonc Technologies, Inc.Phase 1 Not yet recruiting12 enrolled